Adenocarcinoma of the esophagogastric junction: For perioperative chemotherapy, against neoadjuvant radiotherapy

被引：0
作者：
Lordick F. [1 ]
机构：
[1] Medizinische Klinik I (Hämatologie, Zelltherapie, Internistische Onkologie, Hämostaseologie), Universitäres Krebszentrum Leipzig (UCCL), Universitätsklinikum Leipzig, Liebigstr. 22, Leipzig
来源：
Der Onkologe | 2019年 / 25卷 / 12期
关键词：
Combined modality therapy; Esophageal cancer; Gastric cancer; Metastasis; Perioperative care;
D O I：
10.1007/s00761-019-0635-9
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1046 / 1049
页数：3
相关论文
共 50 条
  • [21] Prognostic role of early 18-FDG PET/CT during neoadjuvant chemotherapy for resectable adenocarcinoma of the esophagus and esophagogastric junction
    Harustiak, Tomas
    Zemanova, Milada
    Fencl, Pavel
    Pazdro, Alexandr
    Snajdauf, Martin
    Faltova, Hana
    Lischke, Robert
    Stolz, Alan
    NEOPLASMA, 2021, 68 (02) : 423 - 433
  • [22] Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome
    Glatz, T.
    Bronsert, P.
    Schaefer, M.
    Kulemann, B.
    Marjanovic, G.
    Sick, O.
    Hopt, U. T.
    Zirlik, K.
    Makowiec, F.
    Hoeppner, J.
    EJSO, 2015, 41 (10): : 1300 - 1307
  • [23] Neoadjuvant and adjuvant multimodality therapies in resectable esophagogastric adenocarcinoma
    Lau, David K.
    Athauda, Avani
    Chau, Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (11) : 1429 - 1441
  • [24] Treatment of the Adenocarcinoma of the Esophagogastric Junction at a Single Institution in Mexico
    Luis F. Oñate-Ocaña
    Gonzalo Milán-Revollo
    Vincenzo Aiello-Crocifoglio
    José F. Carrillo
    Dolores Gallardo-Rincón
    Rocío Brom-Valladares
    Roberto Herrera-Goepfert
    Alfonso Dueñas-González
    Annals of Surgical Oncology, 2007, 14 : 1439 - 1448
  • [25] Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico
    Onate-Ocana, Luis F.
    Milan-Revollo, Gonzalo
    Aiello-Crocifoglio, Vincenzo
    Carrillo, Jose F.
    Gallardo-Rincon, Dolores
    Brom-Valladares, Rocio
    Herrera-Goepfert, Roberto
    Duenas-Gonzalez, Alfonso
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) : 1439 - 1448
  • [26] Multimodal treatment of adenocarcinoma of the esophagogastric junction
    Lordick, Florian
    Gockel, Ines
    ONKOLOGE, 2019, 25 (12): : 1086 - 1094
  • [27] Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies
    Hasegawa, Shinichi
    Yoshikawa, Takaki
    GASTRIC CANCER, 2010, 13 (02) : 63 - 73
  • [28] Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
    Stahl, Michael
    Walz, Martin K.
    Stuschke, Martin
    Lehmann, Nils
    Meyer, Hans-Joachim
    Riera-Knorrenschild, Jorge
    Langer, Peter
    Engenhart-Cabillic, Rita
    Bitzer, Michael
    Koenigsrainer, Alfred
    Budach, Wilfried
    Wilke, Hansjochen
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) : 851 - 856
  • [29] Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review
    Abyaneh, Romina
    Ghalehtaki, Reza
    Sanford, Nina N.
    CANCER, 2024, 130 (23) : 4040 - 4051
  • [30] Surgical and perioperative treatment strategy for resectable esophagogastric junction cancer
    Yanagimoto, Yoshitomo
    Kurokawa, Yukinori
    Doki, Yuichiro
    Yoshikawa, Takaki
    Boku, Narikazu
    Terashima, Masanori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (05) : 417 - 424
12345